1 Acetaminophen, an analgesic and antipyretic drug with weak antiin¯ammatory properties, has been suggested to act as a tissue-selective inhibitor of prostaglandin H synthases (PGHSs) (e.g. COX-1 and COX-2) through its reducing activity, that is in¯uenced by the di erent cellular levels of peroxides. 2 We have studied the e ects of acetaminophen on inducible and constitutive prostanoid biosynthesis in monocytes and platelets in vitro. To discriminate between the inhibitory e ect of the drug on PGHS-isozymes vs PGE-synthases (PGESs), parallel measurements of PGE 2 and thromboxane (TX) B 2 were carried out. Since antioxidant enzymes and cofactors, present in plasma, may a ect acetaminophen-dependent inhibition of prostanoids, comparative experiments in whole blood vs isolated monocytes were performed. 3 Acetaminophen inhibited LPS-induced whole blood PGE 2 and TXB 2 production, in a concentration-dependent fashion [IC 50 mM (95% con®dence intervals): 44 (27 ± 70) and 94 (79 ± 112), respectively]. Therapeutic plasma concentrations (100 and 300 mM) of the drug more profoundly reduced PGE 2 than TXB 2 (71+3 vs 54+4 and 95+0.8 vs 78+2%, respectively, mean+s.e.mean, n=6, P50.01). 4 Di erently, in isolated monocytes stimulated with LPS, both PGE 2 and TXB 2 production was maximally reduced by only 60%. 5 At 100 and 300 mM, the drug caused a similar and incomplete inhibition of platelet PGE 2 and TXB 2 production during whole blood clotting (45+4 vs 54+4 and 75+2 vs 75+1%, respectively, mean+s.e.mean, n=4). 6 In conclusion, therapeutic concentrations of acetaminophen caused an incomplete inhibition of platelet COX-1 and monocyte COX-2 but in the presence of plasma, the drug almost completely suppressed inducible PGE 2 biosynthesis through its inhibitory e ects on both COX-2 and inducible PGES.